基于网络药理学与分子对接技术的大黄治疗糖尿病肾病多靶点作用机制研究
Study on the Multi-Target Mechanism of Rheum palmatum in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Technology
摘要: 本研究通过网络药理学与分子对接技术系统研究了大黄治疗糖尿病肾病(DKD)的多靶点作用机制。采用TCMSP数据库筛选大黄16种活性成分及56个药物靶点,整合GeneCards、OMIM和Disgenet数据库获得4301个DKD相关靶基因,通过Venny分析和R语言处理确定41个大黄治疗DKD的潜在基因靶点。利用Cytoscape 3.10.3构建“药物–成分–靶点–疾病”网络,STRING数据库建立蛋白互作网络,经CytoNCA插件分析筛选出包括TNF、TP53、HSP90AA1、CASP3、BCL2、PTGS2、ESR1和MYC在内的核心靶点。分子对接验证显示大黄活性成分与HSP90AA1、BCL2、TNF等靶点具有显著结合亲和力,GO与KEGG富集分析表明其治疗机制涉及炎症反应、细胞凋亡、氧化应激和组织纤维化等多条信号通路的调控,证实了大黄通过“多成分–多靶点–多通路”协同作用治疗DKD的科学机制。这项研究为深入理解中药治疗复杂疾病的网络调控机制提供了重要的理论依据。
Abstract: This study systematically investigated the multi-target mechanism of Rheum palmatum (rhubarb) in treating diabetic kidney disease (DKD) using network pharmacology and molecular docking techniques. Sixteen active components and 56 potential drug targets of rhubarb were identified through the TCMSP database. By integrating data from GeneCards, OMIM, and DisGeNET, 4301 DKD-related target genes were collected. Venny analysis and R software processing revealed 41 key therapeutic targets. Cytoscape 3.10.3 was employed to construct a “drug-component-target-disease” interaction network, while the STRING database was used to establish a protein-protein interaction (PPI) network. Using the CytoNCA plugin, core targets, including TNF, TP53, HSP90AA1, CASP3, BCL2, PTGS2, ESR1, and MYC, were identified. Molecular docking demonstrated strong binding affinity between rhubarb’s active components and key targets (HSP90AA1, BCL2, TNF, etc.). GO and KEGG enrichment analyses indicated that the therapeutic mechanism involves the regulation of multiple pathways, such as inflammatory response, apoptosis, oxidative stress, and tissue fibrosis, confirming rhubarb’s “multi-component, multi-target, multi-pathway” synergistic effect on DKD. This research provides critical theoretical insights into the network regulation mechanisms of traditional Chinese medicine (TCM) in treating complex diseases, supporting the scientific rationale for using rhubarb in DKD therapy.
文章引用:舒淼, 张陈, 杨宸, 张子俊, 吴亮. 基于网络药理学与分子对接技术的大黄治疗糖尿病肾病多靶点作用机制研究[J]. 临床医学进展, 2025, 15(12): 718-730. https://doi.org/10.12677/acm.2025.15123463

参考文献

[1] 王永胜, 杨丽霞, 程涛, 等. 糖尿病肾病的炎症致病机制与中药防治[J]. 中国实验方剂学杂志, 2018, 24(2): 200-207.
[2] 张开弦, 姚秋阳, 吴发明, 等. 大黄属药用植物化学成分及药理作用研究进展[J]. 中国新药杂志, 2022, 31(6): 555-566.
[3] 郭啸华, 刘志红, 戴春笋, 等. 大黄酸抑制TGF-β1诱导的肾小管上皮细胞肥大及细胞外基质产生[J]. 肾脏病与透析肾移植杂志, 2001(2): 101-105.
[4] Yang, S., Zhang, Y. and Zheng, C. (2024) β-Sitosterol Mitigates Apoptosis, Oxidative Stress and Inflammatory Response by Inactivating TLR4/NF-κB Pathway in Cell Models of Diabetic Nephropathy. Cell Biochemistry and Biophysics, 83, 1249-1262. [Google Scholar] [CrossRef] [PubMed]
[5] Valerio, M. and Awad, A.B. (2011) β-Sitosterol Down-Regulates Some Pro-Inflammatory Signal Transduction Pathways by Increasing the Activity of Tyrosine Phosphatase SHP-1 in J774A.1 Murine Macrophages. International Immunopharmacology, 11, 1012-1017. [Google Scholar] [CrossRef] [PubMed]
[6] Dou, F., Liu, Y., Liu, L., Wang, J., Sun, T., Mu, F., et al. (2019) Aloe-Emodin Ameliorates Renal Fibrosis via Inhibiting PI3K/Akt/mTOR Signaling Pathway in Vivo and in Vitro. Rejuvenation Research, 22, 218-229. [Google Scholar] [CrossRef] [PubMed]
[7] Kanlaya, R., Peerapen, P., Nilnumkhum, A., Plumworasawat, S., Sueksakit, K. and Thongboonkerd, V. (2020) Epigallocatechin-3-Gallate Prevents TGF-β1-Induced Epithelial-Mesenchymal Transition and Fibrotic Changes of Renal Cells via GSK-3β/β-Catenin/Snail1 and Nrf2 Pathways. The Journal of Nutritional Biochemistry, 76, Article ID: 108266. [Google Scholar] [CrossRef] [PubMed]
[8] Mohan, T., Velusamy, P., Chakrapani, L.N., Srinivasan, A.K., Singh, A., Johnson, T., et al. (2017) Impact of EGCG Supplementation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis. Journal of Agricultural and Food Chemistry, 65, 8028-8036. [Google Scholar] [CrossRef] [PubMed]
[9] 王娇, 唐俊明, 杨婷, 等. 热休克蛋白90在大鼠糖尿病肾病中的作用及机制[J]. 广东医学, 2018, 39(16): 2419-2423+2427.
[10] Mahmoud, B., Abdel-Moneim, A., Negeem, Z. and Nabil, A. (2022) The Relationship between B-Cell Lymphoma 2, Interleukin-1β, Interleukin-17, and Interleukin-33 and the Development of Diabetic Nephropathy. Molecular Biology Reports, 49, 3803-3809. [Google Scholar] [CrossRef] [PubMed]
[11] DiPetrillo, K., Coutermarsh, B. and Gesek, F.A. (2003) Urinary Tumor Necrosis Factor Contributes to Sodium Retention and Renal Hypertrophy during Diabetes. American Journal of Physiology-Renal Physiology, 284, F113-F121. [Google Scholar] [CrossRef] [PubMed]
[12] Gregorio, K.C.R., Laurindo, C.P. and Machado, U.F. (2021) Estrogen and Glycemic Homeostasis: The Fundamental Role of Nuclear Estrogen Receptors ESR1/ESR2 in Glucose Transporter GLUT4 Regulation. Cells, 10, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
[13] Higgins, C.E., Tang, J., Mian, B.M., Higgins, S.P., Gifford, C.C., Conti, D.J., et al. (2019) TGF-β1-p53 Cooperativity Regulates a Profibrotic Genomic Program in the Kidney: Molecular Mechanisms and Clinical Implications. The FASEB Journal, 33, 10596-10606. [Google Scholar] [CrossRef] [PubMed]
[14] Shen, Y., Miao, N., Wang, B., Xu, J., Gan, X., Xu, D., et al. (2017) c-Myc Promotes Renal Fibrosis by Inducing Integrin ΑV-Mediated Transforming Growth Factor-β Signaling. Kidney International, 92, 888-899. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, B., El Nahas, A.M., Thomas, G.L., Haylor, J.L., Watson, P.F., Wagner, B., et al. (2001) Caspase-3 and Apoptosis in Experimental Chronic Renal Scarring. Kidney International, 60, 1765-1776. [Google Scholar] [CrossRef] [PubMed]
[16] Sun, B. and Karin, M. (2008) NF-κB Signaling, Liver Disease and Hepatoprotective Agents. Oncogene, 27, 6228-6244. [Google Scholar] [CrossRef] [PubMed]
[17] Tümen, D., Heumann, P., Gülow, K., Demirci, C., Cosma, L., Müller, M., et al. (2022) Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines, 10, Article No. 3202. [Google Scholar] [CrossRef] [PubMed]
[18] Lim, A.K. and Tesch, G.H. (2012) Inflammation in Diabetic Nephropathy. Mediators of Inflammation, 2012, Article ID: 146154.
[19] Poznyak, A., Grechko, A.V., Poggio, P., Myasoedova, V.A., Alfieri, V. and Orekhov, A.N. (2020) The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. International Journal of Molecular Sciences, 21, Article No. 1835. [Google Scholar] [CrossRef] [PubMed]
[20] Jiang, W., Gan, C., Zhou, X., Yang, Q., Chen, D., Xiao, H., et al. (2023) Klotho Inhibits Renal ox-LDL Deposition via IGF-1R/RAC1/OLR1 Signaling to Ameliorate Podocyte Injury in Diabetic Kidney Disease. Cardiovascular Diabetology, 22, Article No. 293. [Google Scholar] [CrossRef] [PubMed]